Inmagene Biopharmaceuticals logo

Inmagene Biopharmaceuticals Funding & Investors

It is a leading biotech company focused on immunology-related therapeutic areas.

inmagenebio.com

Total Amount Raised: $121,000,000

Inmagene Biopharmaceuticals Funding Rounds

  • Series C

    $100,000,000

    Series C Investors

    HighLight Capital
    Panacea Venture
    South China Venture Capital
    VMS Asset Management
    TriWise Capital
    Kunlun Fund
    HT Capital
    TMT Investments
  • Series B

    $21,000,000

    Series B Investors

    Vertex Ventures China
    Panacea Venture
    South China Venture Capital
    Kunlun Capital
Funding info provided by Diffbot.